Blueprint for EECA countries, first edition
Review
www.co-hivandaids.com
Volume 12 Number 4 July 2017
Informe sobre poblaciones clave
Accessed November 2017
Rapport sur les populations clès
Accessed November 2017
Recommendations, resources and references
A publication of the Southern African HIV Clinicians Society
Topics in Antiviral Medicine 25 Issue 2 May/June 2017
A compendium of TB REACH case studies, lessons learned and a monitoring and evaluation framework.
Accessed November 2017.
Doc. No.: INS/GDL/001-(Annexes)
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...ted. Initially, due to their high prices, affordability of DAAs was limited in high-, middle- and low-
income countries alike. Now there is a divide between those countries where, because of intellectual
property barriers, prices have remained (very) high and other countries where generics are, or can be,
available at much lower prices. The result is a dual market
more
UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME
AIDS Behav (2017) 21:S23–S33 DOI 10.1007/s10461-016-1670-9
Vreeman RC et al. Journal of the International AIDS Society 2017, 20(Suppl 3):21497 http://www.jiasociety.org/index.php/jias/article/view/21497 | http://dx.doi.org/10.7448/IAS.20.4.21497
Joint Press Release
Stockholm/Copenhagen 20/03/2017
Prepared by NGOs: “Legalife-Ukraine”, “Insight”, “Positive Women”, and “Svitanok”
For the submission to the 66th CEDAW Session Geneva, Switzerland
13 February 2017 - 03 March 2017